Research Center
Cutting-Edge Research Campus in GermanyAI-Driven Drug Discovery & Cross-Disciplinary Innovation
Our campus is powered by a 55 MWp photovoltaic system, producing approximately 55 GWh of clean energy annually ensuring complete energy self-sufficiency and a carbon-positive footprint. Designed to meet the rigorous demands of AI-powered drug discovery, the facility integrates next-generation laboratories, high-performance computing centers, and modular office spaces. The location fosters interdisciplinary collaboration among biotechnologists, chemists, computer scientists, and data analysts, enabling innovation through knowledge exchange and shared resources.
Dedicated spaces for events, workshops, and meetings strengthen cooperation with industry partners and academic institutions. By being situated in Mecklenburg-Vorpommern, we benefit from a supportive regulatory environment, access to skilled professionals, and proximity to European research hubs, positioning us as a leader in sustainable and innovative pharmaceutical research.
The Highlights
Our state-of-the-art research campus spans 60 hectares in Mecklenburg-Vorpommern, Germany, offering 120,000 square meters of specialized indoor facilities. The site is strategically designed to support AI-driven drug discovery, featuring high-performance computing centers, modern laboratories, collaborative workspaces, preclinical testing facilities, and sustainability zones.
The campus operates with complete energy autonomy through our 55 MWp photovoltaic system, generating approximately 55 GWh of clean electricity annually. Our sustainability measures include carbon-positive operations, energy-efficient building design, green spaces, waste reduction programs, and EV charging stations.
Our center combines cutting-edge infrastructure with interdisciplinary collaboration to accelerate drug discovery. Specialized AI computing clusters process massive datasets, while automated laboratories enable high-throughput screening. Integrated workflows connect computational predictions with experimental validation, supported by secure data lakes and modular design for technological adaptation.
We facilitate multiple partnership models, including industry collaborations with pharma companies, academic research agreements, government consortia, startup incubator programs, and technology alliances with AI/cloud service providers.
Our innovative funding ecosystem includes traditional venture capital, strategic partnerships, and the $PCH token system. The token enables community governance, profit-sharing via staking, transparent milestone tracking, and incentives for long-term holders, supplemented by public funding rounds to expand participation.
"AI predicts, Labs test, and Markets decide."
Our cutting-edge research campus bridges AI innovation with real-world drug discovery, accelerating breakthroughs from lab to market.
AI-Driven Drug Discovery
Our 60,000 m² high-performance computing center trains advanced AI models to predict and optimize novel drug candidates at unprecedented speed.
Sustainable Infrastructure
A 55 MWp solar farm powers the entire campus, enabling carbon-positive operations while meeting intensive computational energy demands.
Interdisciplinary Collaboration
Biotech, chemistry, and data science teams work side-by-side in 40,000 m² of modular labs and design spaces to validate AI-generated hypotheses.
Market-Ready Outcomes
From candidate identification to preclinical testing, we streamline the pipeline to deliver investable, clinically viable compounds faster.